A biomimetic tubuloid-on-a-chip for human renal fibrosis research and anti-fibrotic drug development
Journal of Tissue Engineering · 2026-07 · 17
DOI: 10.1177/20417314261472260 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Tissue Engineering, online erschienen am 24.07.2026. Verfasst von Xinyu Zhang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, Zhejiang, China. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Open Research Fund of the State Key Laboratory of Digital Medical Engineering, Ningbo Key Clinical Specialty Construction Project, Frontier Technology Research and Development Program of Jiangsu Province.
Abstract (Originalsprache)
Chronic kidney disease (CKD), driven largely by renal fibrosis, lacks effective therapies due to the limited predictive capacity of existing preclinical models. To address this, we developed a human tubuloid-on-a-chip model integrating tubuloids, endothelial cells, and immune cells within a microfluidic system to recapitulate the key pathophysiology of renal fibrosis. Induction of fibrosis with TGF-β1 in this system recapitulated key pathological features, including extracellular matrix deposition, epithelial-mesenchymal transition, and loss of epithelial polarity. Functional assessments revealed impaired tubular reabsorption, including reduced albumin uptake and glucose transport, alongside elevated oxidative stress, mirroring clinical observations in CKD patients. The model’s pharmacological relevance was validated by the therapeutic effects of nintedanib, which attenuated fibrotic phenotypes. Taken together, this tubuloid-on-a-chip platform demonstrates the potential to model complex fibrotic pathologies in vitro and may serve as a useful tool for CKD research and anti-fibrotic drug development, potentially accelerating therapeutic discovery for renal fibrosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, Zhejiang, China.
- State Key Laboratory of Digital Medicical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing, Jiangsu Province, China; Institute of Microphysiological Systems, Southeast Uni…
- Avatarget Co., Biotechnology Research and Development Department, Laboratory of Organs-on-a-Chip Research, Suzhou, Jiangsu Province, China.
- Department of Urology, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, Zhejiang, China.
ORCID-Profile: Zaozao Chen
Förderung
- Open Research Fund of the State Key Laboratory of Digital Medical Engineering
- Ningbo Key Clinical Specialty Construction Project
- Frontier Technology Research and Development Program of Jiangsu Province
- Basic Research Program of Jiangsu Education Department
- Science and Technology Project of Jiangsu Province
Zitieren
APA
Zhang, X., Yang, F., Han, C., Wang, Y., Liu, X., Wang, Z., Suo, J., Long, H., Zhou, L., Zhang, Z., Song, B., Zhang, J., Li, Q., Gu, Z., Chen, Z., & Shen, Z. (2026). A biomimetic tubuloid-on-a-chip for human renal fibrosis research and anti-fibrotic drug development. Journal of Tissue Engineering, 17. https://doi.org/10.1177/20417314261472260
Vancouver
Zhang X, Yang F, Han C, Wang Y, Liu X, Wang Z, et al. A biomimetic tubuloid-on-a-chip for human renal fibrosis research and anti-fibrotic drug development. Journal of Tissue Engineering. 2026;17. doi:10.1177/20417314261472260
BibTeX
@article{Zhang2026,
author = {Zhang, Xinyu and Yang, Feili and Han, Cheng and Wang, Yina and Liu, Xueqiang and Wang, Zhonghang and Suo, Jichun and Long, Huimin and Zhou, Libin and Zhang, Zilin and Song, Boyang and Zhang, Jing and Li, Qiwei and Gu, Zhongze and Chen, Zaozao and Shen, Zhouji},
title = {A biomimetic tubuloid-on-a-chip for human renal fibrosis research and anti-fibrotic drug development},
journal = {Journal of Tissue Engineering},
year = {2026},
volume = {17},
doi = {10.1177/20417314261472260}
}
EUVIMED